Table 3 Radiologic response rate in all 133 patients (analysed all 159 treatment combinations) and in the 115 patients that only received one lanreotide combination

N = 159 ^a

n = 73

n = 61

Tumour response (%)

 Complete response

1 (0.6)

0

1 (1.6)

 Partial response

22 (13.8)

11 (15.1)

9 (14.8)

 Stable disease

113 (71.1)

49 (67.0)

42 (68.9)

 Progressive disease

13 (8.2)

9 (12.3)

3 (4.9)

 Not evaluated

10 (6.2)

4 (5.5)

6 (9.8)

Patients that received only one lanreotide combination

One treatment combination

n = 115

n = 57

n = 50

Tumour response (%)

 Complete response

1 (0.9)

0

1 (2.0)

 Partial response

20 (17.4)

10 (17.5)

8 (16)

 Stable disease

74 (64.3)

35 (61.5)

34 (68.0)

 Progressive disease

11 (9.6)

8 (14.0)

2 (4.0)

 Not evaluated

9 (7.8)

4 (7.0)

5 (10)